Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 22 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2017DNA barcoding reveals habitual clonal dominance of myeloma plasma cells in the bone marrow microenvironmentHewett, D.; Vandyke, K.; Lawrence, D.; Friend, N.; Noll, J.; Geoghegan, J.; Croucher, P.; Zannettino, A.
2015Neural crest cell-derived VEGF promotes embryonic jaw extensionWiszniak, S.; Mackenzie, F.E.; Anderson, P.; Kabbara, S.; Ruhrberg, C.; Schwarz, Q.
2017Novel selective agents for the degradation of androgen receptor variants to treat castration-resistant prostate cancerPonnusamy, S.; Coss, C.; Thiyagarajan, T.; Watts, K.; Hwang, D.-J.; He, Y.; Selth, L.; McEwan, I.; Duke, C.; Pagadala, J.; Singh, G.; Wake, R.; Ledbetter, C.; Tilley, W.; Moldoveanu, T.; Dalton, J.; Miller, D.; Narayanan, R.
2012Myb-binding protein 1A (MYBBP1A) is essential for early embryonic development, controls cell cycle and mitosis, and acts as a tumor suppressorMori, S.; Bernardi, R.; Laurent, A.; Resnati, M.; Crippa, A.; Gabrieli, A.; Keough, R.; Gonda, T.; Blasi, F.; Plow, E.
2014Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinomaAl-Ejeh, F.; Pajic, M.; Shi, W.; Kalimutho, M.; Miranda, M.; Nagrial, A.; Chou, A.; Biankin, A.; Grimmond, S.; Brown, M.; Khanna, K.
2017Novel androgen receptor coregulator GRHL2 exerts both oncogenic and antimetastatic functions in prostate cancerPaltoglou, S.; Das, R.; Townley, S.; Hickey, T.; Tarulli, G.; Coutinho, I.; Fernandes, R.; Hanson, A.; Denis, I.; Carroll, J.; Dehm, S.; Raj, G.; Plymate, S.; Tilley, W.; Selth, L.
2016Unravelling evolution of Nanog, the key transcription factor involved in self-renewal of undifferentiated embryonic stem cells, by pattern recognition in nucleotide and tandem repeats characteristicsPashaiasl, M.; Khodadadi, K.; Kayvanjoo, A.; Pashaei-asl, R.; Ebrahimie, E.; Ebrahimi, M.
2016Increased miR-155-5p and reduced miR-148a-3p contribute to the suppression of osteosarcoma cell deathBhattacharya, S.; Chalk, A.; Ng, A.; Martin, T.; Zannettino, A.; Purton, L.; Lu, J.; Baker, E.; Walkley, C.
2015Progesterone receptor modulates ERα action in breast cancerMohammed, H.; Russell, I.; Stark, R.; Rueda, O.; Hickey, T.; Tarulli, G.; Serandour, A.; Birrell, S.; Bruna, A.; Saadi, A.; Menon, S.; Hadfield, J.; Pugh, M.; Raj, G.; Brown, G.; D'Santos, C.; Robinson, J.; Silva, G.; Launchbury, R.; Perou, C.; et al.
2015Systematic screening identifies dual PI3K and mTOR Inhibition as a conserved therapeutic vulnerability in osteosarcomaGupte, A.; Baker, E.; Wan, S.; Stewart, E.; Loh, A.; Shelat, A.; Gould, C.; Chalk, A.; Taylor, S.; Lackovic, K.; Karlström, Å.; Mutsaers, A.; Desai, J.; Madhamshettiwar, P.; Zannettino, A.; Burns, C.; Huang, D.; Dyer, M.; Simpson, K.; Walkley, C.